Markus Matilainen
PhD
Turku PET Centre manmat@utu.fi +358 29 450 4739 +358 50 472 8469 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0002-5597-2670 |
Areas of expertise
Statistics; Biostatistics; Blind Source Separation
Statistics; Biostatistics; Blind Source Separation
Publications 
4 of 7
- TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - A review of second-order blind identification methods (2022)
- Wiley Interdisciplinary Reviews: Computational Statistics
(A2 Refereed review article in a scientific journal ) - Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients (2022)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal) - Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - No difference in implant survival between 28-mm M2a RingLoc metal-on-metal and metal-on-polyethylene total hip arthroplasty: results from the Finnish Arthroplasty Register (2022)
- Acta Orthopaedica
(A1 Refereed original research article in a scientific journal) - Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
(A1 Refereed original research article in a scientific journal) - Dimension Reduction for Time Series in a Blind Source Separation Context Using R (2021)
- Journal of Statistical Software
(A1 Refereed original research article in a scientific journal) - Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease (2021)
- Parkinsonism and Related Disorders
(A1 Refereed original research article in a scientific journal) - Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study (2021)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal)
UTU Research Portal